CHD2 and epilepsy: In this study, seven patients with epilepsy were treated with VPA to control their seizures, and it has been reported that VPA has good effect in the treatment of CHD2 mutation (Chen et al., 2020), but for patients with refractory epilepsy, a combination of medications or other methods are needed to control epilepsy.